1 asset in Acute Mountain Sickness
Therapeutic assets addressing Acute Mountain Sickness, rated under Floatz methodology v0.2 and sorted by current rating.
| Asset | Sponsor | Phase | Rating |
|---|---|---|---|
Fremanezumab Acute Mountain Sickness | Insel Gruppe AG, University Hospital Bern | P4 | BB (65) |